ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,326, issued on April 7, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).
"Compositions of GLP-1 peptides and preparation thereof" was invented by Thomas Kvistgaard Vilhelmsen (Solroed Strand, Denmark), Helle Eliasen (Koege, Denmark) and Tue Hansen (Copenhagen S, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hy...